About Concept Pharmaceuticals Limited
Data last updated:
Concept Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 March 1979 and has been in existence for over 47 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1979PLC021126. Its GSTIN is 27AAACC4440M1ZN (Maharashtra). The company holds 19 GST registrations, of which 13 are active.
The company has an authorised share capital of ₹16 Cr and a paid-up capital of ₹12 Cr. It was formerly known as Concept Pharmaceuticals Private Limited. It is led by directors including Yugin Adhyatma Gupta and Ved Parkash Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹222.11 Cr, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹2.62 Cr (net margin 1.2%) and EBITDA of ₹13.72 Cr (EBITDA margin 6.2%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 2% over five years.
The company has about 519 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Concept Pharmaceuticals. As per MCA filings, the company has open charges of ₹280.33 Cr and satisfied charges of ₹77.95 Cr on record. Court records list 309 cases involving the company, including 213 filed by the company and 96 filed against it; 76 cases are pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website conceptpharma.com.
Company details
CIN history
Concept Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239MH1979PTC021126. The current CIN is U24239MH1979PLC021126, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239MH1979PLC021126 | Current |
| U24239MH1979PTC021126 | Previous |
Contact details
Concept Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra. Its website is conceptpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address801 – B Hubtown Solaris N.S. Phadke Marg Off. Teli Galli Near Andheri Flyover A, Ndheri (E), Mumbai, Maharashtra, India – 400069
- IndustryPharma, Drug Formulation & Development, Animal Pharmaceuticals & Healthcare
To see the full contact details of Concept Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Concept Pharmaceuticals operates one associated brand: Concept Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and marketing of pharmaceutical and animal health products with a focus on ethical and global operations. | conceptpharma.com |
Business activity
The main business activity of Concept Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Concept Pharmaceuticals Limited, buy the company report.
Financials of Concept Pharmaceuticals Limited
FY 2024 filings availableConcept Pharmaceuticals Limited reported revenue of ₹222.11 Cr (down 29% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 29% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹222.11 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.72 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.62 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.2% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Concept Pharmaceuticals Limited, buy the company report.
Board of directors of Concept Pharmaceuticals Limited
Concept Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rekha Adhyatma Gupta Also directs: Concept Laboratories Pvt Ltd, Dynamic Machines Private Limited, Jovial Realtors Private Limited and 2 more | Additional Director | 15 Jan 2025 | 1 Years 9 Months | Current |
| Yugin Adhyatma Gupta Also directs: Concept Laboratories Pvt Ltd, Dynamic Machines Private Limited, Jovial Realtors Private Limited and 4 more | Director | 01 Nov 2012 | 13 Years 11 Months | Current |
| Ved Parkash Kumar | Director | 29 Sep 1995 | 31 Years 0 Months | Current |
Peer comparison
Concept Pharmaceuticals Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Animal Pharma, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Salvi Chemical Industries Limited | ₹225.29 Cr (FY 2025) | 47.0% | Mumbai, Maharashtra, India | |||
| Aura Pharmaceuticals Private Limited | ₹223.55 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Venus Biosciences Private Limited | ₹222.32 Cr (FY 2016) | 48.0% | Solan, Himachal Pradesh, India | |||
| Nestor Pharmaceuticals Limited | ₹222.19 Cr (FY 2025) | 8.0% | New Delhi, Delhi, India | |||
| Concept Pharmaceuticals Limitedthis company | ₹222.11 Cr (FY 2024) | ₹2.62 Cr | 1.2% | -29.0% | 519 | Mumbai, Maharashtra, India |
| Naprod Life Sciences Private Limited | ₹219.65 Cr (FY 2025) | 1.0% | Mumbai, Maharashtra, India | |||
| Makson Healthcare Private Limited | ₹217.91 Cr (FY 2024) | -2.0% | Mandideep, Madhya Pradesh, India |
To see the full peer comparison of Concept Pharmaceuticals Limited, buy the company report.
Auditor
Concept Pharmaceuticals Limited is audited by SANJAY P.MUTHE for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY P.MUTHE | FY 2024 | 109177W |
Shareholding
The shareholding of Concept Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Concept Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Feb 2025 | 101069693 | Canara Bank | ₹49 Cr | Open | |
| 14 Oct 2024 | 101003440 | Others | ₹2.5 Cr | Open | |
| 27 Sep 2022 | 100619666 | The Hongkong and Shanghai Banking Corporation Limited | ₹3 Cr | Open | |
| 18 Nov 2021 | 100512046 | Others | ₹3.73 Cr | Open | |
| 12 Mar 2021 | 100432670 | Canara Bank | ₹43 Cr | Open |
To see the full charge records of Concept Pharmaceuticals Limited, buy the company report.
Total charge records: 53 View all charges
Legal cases
Concept Pharmaceuticals Limited has 309 court cases on record: 213 filed by Concept Pharmaceuticals, 96 filed against it. 76 cases are pending and 233 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 197 | 64 | 60 |
| High courts | 110 | 32 | 16 |
| Supreme Court | 1 | 0 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 309)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI BAIL APPLN) | Filed against the company by Manav Drugs Private Ltd Through Bhavesh Gunwantlal Shah, in Appeal 539/2026, Ma 1244/2026 | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI M A) | Filed against the company by Manav Drugs Private Ltd Through Bhavesh Gunwantlal Shah, in Appeal 539/2026, Ba 1724/2026 | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI APPEAL) | Filed against the company by Manav Drugs Private Ltd Through Bhavesh Gunwantlal Shah, Ma 1244/2026, Ba 1724/2026 | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI APPEAL) | Filed against the company by M/S.Pure Life Sciences Pvt. Ltd. and Others @ Ma 2466/23, @ Ba 2855/23 - Applicants. and 2 others | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CRI BAIL APPLN) | Filed against the company by M/S.Pure Life Sciences Pvt. Ltd. and Others in Appeal 803/23, @ Ma 2466/23 - Applicants. and 2 others | Disposed |
To see the full case history of Concept Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Concept Pharmaceuticals Limited was last rated by Crisil on 28 Jul 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 28 Jul 2020 |
To see the full credit ratings and regulatory alerts of Concept Pharmaceuticals Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Concept Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Concept Pharmaceuticals Limited has a workforce of 519 employees on its EPFO records as of Mar 29, 2025, across 2 active EPFO establishments.
GST
Concept Pharmaceuticals has 19 GST registrations: 13 active and 6 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACC4440M1ZN | Maharashtra | Active | 01 Jul 2017 |
| 03AAACC4440M1ZX | Punjab | Active | 01 Jul 2017 |
| 05AAACC4440M1ZT | Uttarakhand | Active | 01 Jul 2017 |
| 06AAACC4440M1ZR | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Concept Pharmaceuticals Limited, buy the company report.
Recent activity
Concept Pharmaceuticals Limited has 6 board changes on record since 1995: 3 appointments and 3 cessations. The latest: Rekha Adhyatma Gupta was appointed as Additional Director on 15 Jan 2025.
80 earlier events are in the company report.
Frequently asked questions
Concept Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 March 1979 (47+ years old) and is registered under CIN U24239MH1979PLC021126.
Concept Pharmaceuticals has 3 current directors:
- Rekha Adhyatma Gupta - Additional Director
- Yugin Adhyatma Gupta - Director
- Ved Parkash Kumar - Director
The latest financial statements of Concept Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Concept Pharmaceuticals is 27AAACC4440M1ZN, registered in Maharashtra. The company has 19 GST registrations in all, of which 13 are active and 6 are cancelled or inactive. Other active GSTINs include 03AAACC4440M1ZX (Punjab), 05AAACC4440M1ZT (Uttarakhand), 06AAACC4440M1ZR (Haryana).
The CIN (Corporate Identification Number) of Concept Pharmaceuticals is U24239MH1979PLC021126. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Concept Pharmaceuticals has 309 court cases on record: 213 filed by the company and 96 filed against it. 76 are pending. Most are in the district courts.
Concept Pharmaceuticals was incorporated on 20 March 1979, making it 47+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Concept Pharmaceuticals by revenue are Salvi Chemical Industries Limited, Aura Pharmaceuticals Private Limited, Venus Biosciences Private Limited, Nestor Pharmaceuticals Limited, Naprod Life Sciences Private Limited and 1 more, all in the Pharma industry (Animal Pharma, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rekha Adhyatma Gupta was appointed as Additional Director on 15 Jan 2025. Adhyatma Bandhu Gupta ceased to be Managing Director on 08 Jan 2025. Yugin Adhyatma Gupta ceased to be Additional Director on 30 Mar 2013. Concept Pharmaceuticals has 6 board changes on record in total.
Concept Pharmaceuticals can be reached through the website conceptpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Concept Pharmaceuticals is at 801 – B Hubtown Solaris N.S. Phadke Marg Off. Teli Galli Near Andheri Flyover A, Ndheri E, Mumbai, Maharashtra, India – 400069.